|Articles|May 15, 2002
- BioPharm International-05-01-2002
- Volume 15
- Issue 5
Washington Report: Vaccine Shortages put Spotlight on Production
Author(s)Jill Wechsler
by Jill Wechsler Bioterrorism and common infections create challenges for manufacturers.
Advertisement
Articles in this issue
over 23 years ago
Info+over 23 years ago
Analytical Advances: Strategies in Clarifying Mammalian Culturesover 23 years ago
Analytical Advances: Using Image Informatics - Focusing Proteomicsover 23 years ago
The Not-So-Sure Thingover 23 years ago
Guest Editorial: Validation Bingoover 23 years ago
Travel Notes: Yes, Virginia, There is Biotech in the CommonwealthNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
FDA-Approved WAS Gene Therapy Hits Market in Nonprofit Model
2
Charles River Incubator Cohort to Accelerate CGT Development
3
FAQ: Shifts in FDA Regulations and Strategies in 2025
4
Two-Minute Mysteries: BioPharm Stories - Episode 2: The Costly Myth of Noninvasive Glucose Monitoring
5
